The division of Pulmonary & Critical Care Medicine had a busy fall, including holding its first-ever 2024 Advanced Respiratory Disease and Lung Transplant Summit, presented in partnership with NewYork-Presbyterian/Columbia University Medical Center. Held on September 26, 2024, the day-long conference opened with welcoming remarks from Dr. Anna Podolanczuk and featured faculty from both NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian/Columbia University Medical...
Dr. Fernando J. Martinez, Chief of the Division of Pulmonary and Critical Care Medicine (PCCM), has accepted the role of Academic Chief of Pulmonary, Allergy, and Critical Care Medicine and Vice Chair for Clinical and Translational Research at the University of Massachusetts and will be leaving Weill Cornell Medicine at the end of June.
Dr. Martinez has made numerous contributions to the WDOM and to PCCM over the last 10 years and has positively...
On March 29, the division of Pulmonary and Critical Care Medicine held its third annual Pulmonary Academic Day, an opportunity for cross-divisional, cross-departmental, and cross-campus collaboration for faculty, trainees, and postdoctoral fellows across the Weill Cornell Medicine community. Faculty shared investigative interactions, showcased emerging research, and engaged in lively forums to discuss exciting findings within the field of pulmonary, sleep and critical care medicine....
The Weill Department of Medicine is deeply saddened by the loss of Dr. James P. Smith, Jr., who passed away last week. A renowned, long-time member of our faculty, Dr. Smith helped pioneer the research and treatment of Chronic Obstructive Pulmonary Disease (COPD), lung cancer, and tuberculosis. A key clinical breakthrough, along with celebrated pulmonologist Dr. Lawrence Scharer, was developing the use of closed pleural biopsy with the Abrams needle in the diagnosis of tuberculosis. Dr....
Researchers at Weill Cornell Medicine have discovered a protein that plays a critical role in clearing collagen from tissue and may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function. The paper, published on Feb. 20 in Nature Communications, provides clues that could lead to drug development for diseases like lung fibrosis which have no drug options currently.Corresponding author, Dr. Michael J. Podolsky, Assistant Professor of Medicine...
The feature "Getting Back to Basics: Dr. Hasina Outtz Reed's Mission to Uncover the Origins of Lung Disease" is among the features in the Department's 2023 Annual Report.When Dr. Hasina Outtz Reed pursued a Ph.D. in science, she knew she wanted her work to directly impact people. “I wanted to have the ability to use my knowledge to see how science related to medicine and patient care, particularly translational medicine,” she says. Today, Dr. Outtz Reed, the James Hilton Manning and...
The study is focused on whether doxycycline may slow the progression of emphysema (a type of chronic obstructive pulmonary disease), in people with well-controlled HIV who are current or former smokers.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the U.S.
IPF, which causes progressive scarring of the lungs due to chronic lung inflammation, is usually fatal because it tends to be diagnosed late in the process when treatments are less effective.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
